FRAME appoints senior scientific liaison officer

Amy Schofield 14 February 2018

FRAME, a medical research charity committed to replacing the use of animals in scientific experiments, has appointed Amy Beale as senior scientific liaison officer as it embarks on a major profile raising campaign.

Beale, a graduate in Equine Science from DMU, has joined FRAME from an educational background as a science teacher. She has always been passionate about promoting positive animal welfare messages through science and previously worked for RSPCA Education. In this role she was responsible for promoting animal welfare resources to teachers and school children.

Her new role would involve engaging with new and existing supporters and stakeholders of FRAME to promote the activities of the charity. She will also be responsible for identifying potential sources of funding for FRAME and for initiating fundraising activities through charitable trusts and grant applications.

Beale will also organise events promoting FRAME such as scientific symposia, and work with FRAME staff and trustees to promote the values and activities of FRAME via the internet and social media. She says that she was attracted to the charity because it has a scientific approach to ending animal testing.

She said: “I have always had an interest in issues affecting animal welfare and it was at the RSPCA that I first heard about the three ‘R’s – replacement, reduction and refinement – as a way forward for ultimately ending animal experimentation. This is a philosophy I fully support, and am committed to raising awareness of.

“It is all about reducing the number of animals used in bio-medical research, replacing experimentation using animals with scientifically proven alternatives that don’t, and refining existing practices to reduce suffering.”

Beale added: “For me, this is not an issue about animal rights but about improving animal welfare. Ultimately the aim is to eliminate the need for using any animals in medical and scientific research. Unfortunately, at the moment, this is not possible due to a lack of alternative non-animal methods, coupled with regulatory requirements. In order to achieve this aim, scientists need to be developing and researching new techniques and promoting awareness of them – and this is exactly what FRAME does.”

Dr Anna Cadogan, chair of trustees at FRAME, said: “We are pleased to welcome Amy as part of our team. She will play a vital role in taking FRAME to the next level as we seek to raise our profile and attract the backing of new sponsors. This will enable us to build on the excellent work our scientists are already carrying out, which in itself would not have been possible without our existing list of committed corporate supporters.”


Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.